SitesBLAST
Comparing WP_034273571.1 NCBI__GCF_000504245.1:WP_034273571.1 to proteins with known functional sites using BLASTp with E ≤ 0.001.
Or try Sites on a Tree, PaperBLAST, Conserved Domains, or compare to all protein structures
Found 20 (the maximum) hits to proteins with known functional sites (download)
3dc2A Crystal structure of serine bound d-3-phosphoglycerate dehydrogenase from mycobacterium tuberculosis (see paper)
64% identity, 98% coverage: 7:528/531 of query aligns to 2:523/526 of 3dc2A
- active site: N96 (= N101), R230 (= R235), D254 (= D259), E259 (= E264), H277 (= H282)
- binding serine: Y458 (= Y463), D460 (= D465), R461 (= R466), P462 (= P467), G463 (= G468), A464 (≠ V469), L465 (≠ M470), L484 (≠ I489)
3ddnB Crystal structure of hydroxypyruvic acid phosphate bound d-3- phosphoglycerate dehydrogenase in mycobacterium tuberculosis (see paper)
64% identity, 98% coverage: 7:528/531 of query aligns to 3:522/525 of 3ddnB
O43175 D-3-phosphoglycerate dehydrogenase; 3-PGDH; 2-oxoglutarate reductase; Malate dehydrogenase; EC 1.1.1.95; EC 1.1.1.399; EC 1.1.1.37 from Homo sapiens (Human) (see 3 papers)
37% identity, 76% coverage: 1:406/531 of query aligns to 1:410/533 of O43175
- M1 (= M1) modified: Initiator methionine, Removed
- A2 (≠ T2) modified: N-acetylalanine
- T78 (≠ V77) binding NAD(+)
- R135 (= R134) to W: in PHGDHD; results in a 2-fold decrease in enzyme activity with 3-phosphohydroxypyruvate, but no change in substrate affinity; dbSNP:rs267606949
- RI 155:156 (≠ KI 154:155) binding NAD(+)
- D175 (= D174) binding NAD(+)
- T207 (≠ L206) binding NAD(+)
- CAR 234:236 (≠ AAR 233:235) binding NAD(+)
- D260 (= D259) binding NAD(+)
- V261 (= V260) to M: in PHGDHD; results in a four-fold decrease in substrate affinity and a slight increase in maximal enzyme activity with 3-phosphohydroxypyruvate; dbSNP:rs267606947
- HLGA 283:286 (= HLGA 282:285) binding NAD(+)
- A373 (= A370) to T: in PHGDHD; results in almost undetectable enzyme activity with 3-phosphohydroxypyruvate; dbSNP:rs201553627
- G377 (= G374) to S: in PHGDHD; results in a 2-fold decrease in enzyme activity with 3-phosphohydroxypyruvate, but no change in substrate affinity; dbSNP:rs267606948
Sites not aligning to the query:
- 425 V → M: in PHGDHD; results in almost undetectable enzyme activity with 3-phosphohydroxypyruvate; dbSNP:rs121907988
- 490 V → M: in PHGDHD; results in almost undetectable enzyme activity with 3-phosphohydroxypyruvate; dbSNP:rs121907987
7dkmA Phgdh covalently linked to oridonin (see paper)
41% identity, 55% coverage: 9:299/531 of query aligns to 5:296/306 of 7dkmA
- binding nicotinamide-adenine-dinucleotide: T74 (≠ V77), A102 (= A105), G148 (= G151), R151 (≠ K154), I152 (= I155), Y170 (= Y173), D171 (= D174), P172 (= P175), I173 (≠ Y176), H202 (= H205), T203 (≠ L206), P204 (= P207), T209 (= T212), C230 (≠ A233), A231 (= A234), R232 (= R235), H279 (= H282), G281 (= G284)
- binding (1beta,6beta,7beta,8alpha,9beta,10alpha,13alpha,14R,16beta)-1,6,7,14-tetrahydroxy-7,20-epoxykauran-15-one: C14 (≠ S18), K17 (≠ E21), I18 (≠ V22), E293 (≠ T296)
6rj3A Crystal structure of phgdh in complex with compound 15 (see paper)
41% identity, 55% coverage: 9:299/531 of query aligns to 3:294/297 of 6rj3A
6cwaA Crystal structure phgdh in complex with nadh and 3-phosphoglycerate at 1.77 a resolution (see paper)
41% identity, 55% coverage: 9:299/531 of query aligns to 3:294/299 of 6cwaA
- binding 1,4-dihydronicotinamide adenine dinucleotide: N96 (= N101), A100 (= A105), R149 (≠ K154), I150 (= I155), Y168 (= Y173), D169 (= D174), P170 (= P175), I171 (≠ Y176), H200 (= H205), T201 (≠ L206), P202 (= P207), T207 (= T212), C228 (≠ A233), A229 (= A234), R230 (= R235), H277 (= H282), G279 (= G284)
6plgA Crystal structure of human phgdh complexed with compound 15 (see paper)
41% identity, 55% coverage: 9:299/531 of query aligns to 4:295/303 of 6plgA
7ewhA Crystal structure of human phgdh in complex with homoharringtonine (see paper)
41% identity, 55% coverage: 9:299/531 of query aligns to 4:295/302 of 7ewhA
- binding (3beta)-O~3~-[(2R)-2,6-dihydroxy-2-(2-methoxy-2-oxoethyl)-6-methylheptanoyl]cephalotaxine: L146 (≠ V150), G147 (= G151), L148 (= L152), G149 (= G153), R150 (≠ K154), I151 (= I155), G152 (= G156), D170 (= D174), H201 (= H205), T202 (≠ L206), P203 (= P207)
6rihA Crystal structure of phgdh in complex with compound 9 (see paper)
41% identity, 55% coverage: 9:299/531 of query aligns to 4:295/302 of 6rihA
6rj2A Crystal structure of phgdh in complex with compound 40 (see paper)
41% identity, 55% coverage: 9:299/531 of query aligns to 1:292/299 of 6rj2A
- binding ~{N}-[(1~{R})-1-[4-(ethanoylsulfamoyl)phenyl]ethyl]-2-methyl-5-phenyl-pyrazole-3-carboxamide: G146 (= G153), I148 (= I155), Y166 (= Y173), D167 (= D174), P168 (= P175), I169 (≠ Y176), I170 (≠ V177), H198 (= H205), T199 (≠ L206), L208 (= L215), R228 (= R235)
6plfA Crystal structure of human phgdh complexed with compound 1 (see paper)
41% identity, 55% coverage: 9:299/531 of query aligns to 5:296/305 of 6plfA
6rj5A Crystal structure of phgdh in complex with compound 39 (see paper)
41% identity, 55% coverage: 9:299/531 of query aligns to 4:295/301 of 6rj5A
6plfB Crystal structure of human phgdh complexed with compound 1 (see paper)
41% identity, 55% coverage: 9:299/531 of query aligns to 3:286/292 of 6plfB
- binding 4-{(1S)-1-[(5-chloro-6-{[(5S)-2-oxo-1,3-oxazolidin-5-yl]methoxy}-1H-indole-2-carbonyl)amino]-2-hydroxyethyl}benzoic acid: R141 (≠ K154), Y160 (= Y173), D161 (= D174), P162 (= P175), I164 (≠ V177), L179 (= L192), T193 (≠ L206), P194 (= P207), S198 (≠ E211), L202 (= L215)
1wwkA Crystal structure of phosphoglycerate dehydrogenase from pyrococcus horikoshii ot3
44% identity, 56% coverage: 9:308/531 of query aligns to 3:304/304 of 1wwkA